Earnings summaries and quarterly performance for VEEVA SYSTEMS.
Executive leadership at VEEVA SYSTEMS.
Board of directors at VEEVA SYSTEMS.
Research analysts who have asked questions during VEEVA SYSTEMS earnings calls.
Brian Peterson
Raymond James Financial
7 questions for VEEV
Craig Hettenbach
Morgan Stanley
7 questions for VEEV
David Larsen
BTIG
7 questions for VEEV
Jailendra Singh
Truist Securities
6 questions for VEEV
Steven Valiquette
Mizuho
6 questions for VEEV
Tyler Radke
Citigroup Inc.
6 questions for VEEV
Brent Bracelin
Piper Sandler Companies
5 questions for VEEV
Charles Rhyee
TD Cowen
5 questions for VEEV
Dylan Becker
William Blair
5 questions for VEEV
Gabriela Borges
Goldman Sachs
5 questions for VEEV
Ken Wong
Oppenheimer & Co. Inc.
5 questions for VEEV
Saket Kalia
Barclays Capital
5 questions for VEEV
Andrew DeGasperi
BNP Paribas
4 questions for VEEV
David Hynes
Canaccord Genuity Group Inc.
4 questions for VEEV
Joe Vruwink
Baird
4 questions for VEEV
Rishi Jaluria
RBC Capital Markets
4 questions for VEEV
Ryan MacDonald
Needham & Company
4 questions for VEEV
S. Kirk Materne
Evercore ISI
4 questions for VEEV
Stan Berenshteyn
Wells Fargo Securities
4 questions for VEEV
David Windley
Jefferies Financial Group Inc.
3 questions for VEEV
Jeffrey Garro
Stephens Inc.
3 questions for VEEV
Joseph Vruwink
Baird
3 questions for VEEV
Stanislav Berenshteyn
Wells Fargo
3 questions for VEEV
Alexei Gogolev
JPMorgan Chase & Co.
2 questions for VEEV
Alina Sukhotkalia
Barclays
2 questions for VEEV
Allan Verkhovski
Scotiabank
2 questions for VEEV
Andrew DeGasbury
BNP Paribas
2 questions for VEEV
Hoi-Fung Wong
Oppenheimer & Co. Inc.
2 questions for VEEV
Jeff Garro
Stephens
2 questions for VEEV
Tucker Remmers
Jefferies
2 questions for VEEV
Anne McCormick
JPMorgan Chase & Co.
1 question for VEEV
Anne Samuel
JPMorgan Chase & Co.
1 question for VEEV
Bradley Sills
Bank of America
1 question for VEEV
Carolyn Valenti
Goldman Sachs Group, Inc.
1 question for VEEV
Faith Brunner
William Blair
1 question for VEEV
Jack Wallace
Guggenheim Partners
1 question for VEEV
Jenny Cao
Truist Securities
1 question for VEEV
Peter Griffith
Citigroup
1 question for VEEV
Sean Dodge
RBC Capital Markets
1 question for VEEV
William McNamara
Evercore ISI
1 question for VEEV
Recent press releases and 8-K filings for VEEV.
- Veeva Systems has launched Veeva AI Agents for Vault CRM and PromoMats, marking a major milestone for its industry-specific AI in life sciences.
- These new AI Agents are designed to enhance productivity and customer centricity within the life sciences industry.
- For Vault CRM, new agents include Free Text Agent, Voice Agent, and Pre-call Agent, while PromoMats now features Quick Check Agent and Content Agent.
- Additional Veeva AI Agents for clinical, regulatory, safety, quality, medical, and commercial applications are planned for release throughout 2026.
- Veeva Systems reported total revenue of $811 million and non-GAAP operating income of $365 million for Q3 2026, exceeding its guidance.
- The company is significantly investing in Veeva AI, with an accelerated roadmap to integrate AI agents into virtually all applications by the end of 2026, aiming to drive value across commercial and R&D.
- While the CRM suite now accounts for approximately 20% of total revenue and is considered a stable business, other segments like Crossix are experiencing very healthy growth, and the R&D and Quality Clouds show strong performance and significant greenfield opportunities.
- Despite a reduction in top 20 CRM customers from 18 to potentially 14, management remains confident in achieving its 2030 goals, emphasizing the diversity of its business and the integrated platform's competitive advantage.
- The company raised its Q4 guidance, citing improved visibility, earlier deal closures, and broad strength across its business segments.
- Veeva Systems reported strong fiscal Q3 2026 results for the quarter ended October 31, 2025, with total revenue of $811 million and non-GAAP operating income of $365 million.
- The company is making excellent progress with Veeva AI, a major initiative with an accelerated agent roadmap to integrate AI into virtually all applications by the end of 2026.
- For Vault CRM, 14 out of the top 20 customers are expected to migrate, while 6 are opting for other solutions; CRM currently accounts for about 20% of total revenue, down from 25% two years ago, with no material impact on 2030 goals expected from these transitions.
- Veeva continues to see strong performance in its Development Cloud, with 20 out of the top 20 customers selecting Veeva for eCTMF, and healthy growth in its Crossix business.
- The company raised its Q4 guidance due to improved visibility and broad strength across its commercial, R&D, and services businesses, including earlier deal closures.
- Veeva Systems (VEEV) reported Q3 2026 total revenue of $811 million, an increase of 16% year-over-year, with Non-GAAP operating income of $365 million and a Non-GAAP operating margin of 45.0%.
- For Q4 2026, the company provided guidance for total revenue between $807 million and $810 million, Non-GAAP operating income of approximately $350 million, and Non-GAAP fully diluted net income per share of about $1.92.
- VEEV also updated its FY 2026 guidance, projecting total revenue between $3,166 million and $3,169 million, Non-GAAP operating income of approximately $1,417 million, and Non-GAAP fully diluted net income per share of about $7.93.
- Veeva Systems reported total revenue of $811 million and non-GAAP operating income of $365 million for Q3 2026, with results above guidance.
- The company is making significant progress with Veeva AI, a major initiative, and plans to have AI agents in virtually all software applications by the end of 2026, including commercial, CRM, safety, quality, clinical operations, and clinical data management.
- Regarding Vault CRM, 14 out of 20 top 20 customers are expected to migrate, while 6 may opt for other solutions, though no material revenue impact is expected in the short term, and Veeva anticipates potential win-backs. CRM currently accounts for about 20% of total revenue.
- Crossix continues to be a strong growth driver, with healthy performance year-to-date, benefiting from increasing digital marketing spending and its role in measurement and optimization.
- Veeva sees the life sciences industry as healthy and stable, with continued demand driven by scientific advancements, and maintains a strong competitive position due to its integrated platform and long-term commitment to the industry.
- VEEV reported Q3 2026 total revenue of $811.2 million and Non-GAAP operating income of $364.9 million, resulting in a Non-GAAP operating income margin of 45.0%.
- For Q4 2026, the company provided guidance for total revenue between $807-810 million, Non-GAAP operating income of ~ $350 million, and Non-GAAP fully diluted net income per share of ~ $1.92.
- VEEV's FY 2026 guidance includes total revenue of $3,166-3,169 million, Non-GAAP operating income of ~ $1,417 million, Non-GAAP fully diluted net income per share of ~ $7.93, Non-GAAP operating cash flow of ~ $1,335 million, and Normalized Billings of ~ $3,369 million.
- Veeva Systems reported total revenues of $811.2 million for the third quarter ended October 31, 2025, marking a 16% increase year over year. Subscription services revenues grew by 17% year over year to $682.5 million.
- For the third quarter, fully diluted net income per share was $1.40, while non-GAAP fully diluted net income per share was $2.04.
- The company provided updated guidance for fiscal year ending January 31, 2026, expecting total revenues between $3,166 million and $3,169 million and non-GAAP fully diluted net income per share of approximately $7.93.
- Veeva continues to advance its AI initiatives, with the first agents for CRM and commercial content on track for release in early December, and also reported 23 new customer additions for Veeva Vault CRM.
- Veeva Systems reported total revenues of $811.2 million for the third quarter ended October 31, 2025, an increase of 16% year over year.
- Non-GAAP fully diluted net income per share for Q3 2026 was $2.04, compared to $1.75 one year ago.
- The company updated its fiscal year ending January 31, 2026, guidance, projecting total revenues between $3,166 million and $3,169 million, and non-GAAP fully diluted net income per share of approximately $7.93.
- Veeva AI is progressing with the first agents for CRM and commercial content on track for release in early December, and Veeva Vault CRM added 23 new customers, reaching a total of 115 live customers.
- Veeva is on track to achieve its $6 billion revenue goal for calendar year 2030, primarily through organic growth and existing life sciences products, having already met its 2025 revenue target.
- The company is making significant progress with Veeva.ai, an agentic AI offering for life sciences, with the first commercial product release scheduled for December and other Vault areas throughout 2026, and plans to start charging for it next year.
- Veeva's total addressable market (TAM) is estimated at $20 billion, with the company currently 16% penetrated, indicating a long runway for growth.
- A new markets initiative, focusing on horizontal enterprise applications, is underway, with the first application in the CRM area expected to go live with early customers in Q1; this initiative is not factored into the 2030 revenue goal.
- Non-GAAP operating margins were 45% in Q2, with a 35% floor set for 2030, allowing for potential outsized investment.
- Veeva is on track to achieve its 2030 revenue goal of $6 billion, having already achieved its 2020 goal of $1 billion and 2025 goal of $3 billion.
- For Q3'26, Veeva provided guidance including total revenue of $790-793 million, non-GAAP operating income of $348-350 million, and non-GAAP fully diluted net income per share of $1.94-1.95.
- The company is expanding into new markets, specifically horizontal enterprise applications, with a potential market size of $100 billion+, and is integrating Agentic AI across its Vault Platform and applications.
- Veeva continues to see a long runway for growth in the life sciences industry, with a total addressable market (TAM) of $20 billion+ that is currently only ~16% penetrated.
Quarterly earnings call transcripts for VEEVA SYSTEMS.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track VEEVA SYSTEMS's earnings for you
Get instant analysis when filings drop